Maxygen
NASDAQ:MAXY
$5.67
-$0.06
(-1.05%)
Quote as of 4:00 PM EST on 02/09/12
Maxygen Announces $10 Million Stock Repurchase Program
Maxygen announces $10M stock rpurchase program
Maxygen Announces $10 Million Stock Repurchase Program
Maxygen 'surprised' by US BARDA radiation treatment contract rejection
BARDA Rejects Maxygenâs Proposal to Develop MAXY-G34 for Acute Radiation Syndrome
Maxygen not to awarded contract for development of Maxy-G34 by BARDA
Maxygen Reports Third Quarter 2011 Financial Results
Maxygen Reports Third Quarter 2011 Financial Results
Maxygen (MAXY) Shares Rise Amid Final Rejection of All Claims of Amgen '804 Patent
Maxygen's board approves $10M boost to repurchase plan
Maxygen's board approves $10M stock boost
Maxygen Announces $10 Million Increase in Stock Repurchase Program
Maxygen (MAXY) Boosts Buyback by $10M Common
Maxygen announces $10M increase in stock repurchase program
Maxygen Announces $10 Million Increase in Stock Repurchase Program
Maxygen Reports Second Quarter 2011 Financial Results
Sale gain boosts Maxygen Q2 profit to $54.5M
Maxygen (MAXY) Reports Q2 Earnings of $1.86
Hatteras’ Ken Lee joins BioCryst board
Maxygen Announces $10 Million Stock Repurchase Program
Maxygen plans $10M stock repurchase
Maxygen (MAXY) Board Authorizes $10M Buyback Program
Maxygen Announces $10 Million Stock Repurchase Program
Astellas and Maxygen Announce Completion of Acquisition of Perseid by Astellas
Hedge Fund Centaur Capital Buys CSTR, WDC, DELL, AHL, DO, CSCO, Sells NOC, VOD, BH, LH, EMC
Maxygen Reports First Quarter 2011 Financial Results
Maxygen swings to profit in Q1
Maxygen Submits Proposal To BARDA For Development Of MAXY-G34 For Acute Radiation Syndrome
Maxygen Submits Proposal to BARDA for Development of MAXY-G34 for Acute Radiation Syndrome
Maxygen submitts proposal to the BARDA for development of MAXY-G34
Whitney Tilson's 17 Newest Stock Picks From February: Part 2
Maxygen Shares Soar on Joint Venture Buyout
Astellas acquiring Maxygen joint venture for $76M
Astellas buys out Maxygen stake in JV for $76M
